Pharmacological developments in male contraception

Area of Science:

• Reproductive biology
• Pharmacology
• Urology

Background:

• Current male contraception options (condoms, coitus interruptus, vasectomy) have significant drawbacks including inconvenience, reduced pleasure, high failure rates, and near-sterilization.
• Existing methods necessitate male involvement and often carry a substantial burden of side effects or inconvenience.

Purpose of the Study:

• To review recent advancements in male contraceptive research, evaluating novel hormonal and non-hormonal approaches.
• To analyze the mechanisms of action, benefits, and limitations of emerging male contraceptive strategies.

Main Methods:

• Review of clinical and animal studies on male contraceptive agents.
• Analysis of compounds targeting spermatogenesis (hormonal and non-hormonal) and post-testicular sperm functions.
• Evaluation of gonadotropin-releasing hormone (GnRH) antagonism as a contraceptive strategy.

Main Results:

• Hormonal agents, primarily testosterone esters (alone or with progestogens), are nearing development for suppressing sperm production.
• Gonadotropin-releasing hormone (GnRH) antagonism shows promise in suppressing gonadotropins, impacting fertility.
• Non-hormonal antispermatogenic agents (phytochemicals, enzyme inhibitors) and post-testicular agents (affecting sperm metabolism, motility, maturation, or transport) are under investigation.

Conclusions:

• Diverse research avenues are exploring new male contraceptive methods, moving beyond traditional options.
• Hormonal and non-hormonal agents targeting sperm production and function represent promising future directions in male fertility control.
• Further research is needed to establish the efficacy, safety, and practicality of these novel male contraceptive strategies.